Leukotriene E4 was metabolized to two polar products by rat liver microsomes. These products were characterized by physico-chemical and chemical techniques. The chemical structures, (SS, 6R)-5,20-dihydroxy-6S-cysteinyl-7,9-trans-ll,l4-cis-icosatetraenoic acid (w-hydroxy-leukotriene E4) and (SS, 6R)-S-hydroxy-6S-cysteinyl-7,9-fruns-11,14-cis-icosatetraen-l,20-dioic acid (w-carboxy-leukotriene E,) suggested that leukotriene E4 was transformed by an o-hydroxylase and o-hydroxyleukotriene E dehydrogenase in sequence. N-Acetylleukotriene E4 was also transformed by these enzymes, but at a rate six times lower than leukotriene E4. The products formed from N-acetylleukotriene E4 were characterized as being N-acetyl-o-hydroxy-leukotriene E4 and N-acetyl-w-carboxy-leukotriene E4. Other substrates were 11 -trans-leukotriene E4 and N-acetyl-1 1 -transleukotriene E4. In contrast, leukotrienes C4 and D4 were not converted into o-oxidized metabolites. The leukotriene E o-hydroxylase reaction required NADPH and molecular oxygen as cofactors, and was most rapidly catalyzed by liver microsomes. Liver cytosol, fortified with NAD' , converted o-hydroxyleukotriene E4 and N-acetyl-o-hydroxy-leukotriene E4 into o-carboxy metabolites. Microsomes contained at least 18 times less w-hydroxy-leukotriene E dehydrogenase activity than did cytosol. Liver microsomes supplemented with acetylcoenzyme A converted w-hydroxy and o-carboxy-leukotriene E4 into the corresponding N-acetyl derivatives. The novel enzyme, leukotriene E o-hydroxylase, which is described here is distinct from a previously described leukotriene B w-hydroxylase based on substrate competition and kinetic data.Previous investigations in our and other laboratories have shown that cysteine-containing leukotrienes [2] are extensively metabolized both in vitro and in vivo (reviewed in [3]). Following administration of tritium-labeled leukotriene C,, a biliary and two fecal metabolites in the rat (N-acetylleukotriene E4 and N-acetyl-11-trans-leukotriene E4 [4, 5]), a biliary metabolite in the guinea pig (leukotriene D4 [6]) and a biliary and urinary compound in pig and monkey and a urinary metabolite in man (leukotriene E4 [7 -91) were characterized. During the course of these and other (e.g. [lo, 111) investigations it was found that more polar metabolites were also formed from LTC. The relative amount of the latter compounds increased with time following LTC administration. Since a large Correspondence to L. Orning, Institutionen for Fysiologisk Kemi, Karolinska Institutet, S-104 01 Stockholm, SwedenAbbreviations. RP-HPLC, reverse-phase high-performance liquid chromatography; FAB-MS, fast-atom-bombardment mass spectrometry; GC-MS, gas-liquid chromatography/mass spectrometry; Me,Si, trimethylsilyl; LTB4, leukotriene B4; LTC4, leukotriene C4; LTD4, leukotriene D4; LTE4, leukotriene E4; N-Ac-LTE4, Nacetylleukotriene E4; 11 -trans-LTC4, 1 1-trans-leukotriene C4; 11-trans-LTE4, 1 1-trans-leukotriene E4; N-Ac-11 -trans-LTE4, N-acetyl-1 1-trans-leukotriene Ed; w-OH-LTE4, w-hydroxy-leukot...